Terbutaline: Label Change – Warnings Against Use for Treatment of Preterm Labor
Audience: OBGYN, Family Practice ISSUE: FDA notified healthcare professionals that injectable terbutaline should not be used in pregnant women for prevention or prolonged treatment (beyond 48-72 hours) of preterm labor in either the hospital or…
No related posts.
facebook
rss
twitter